The Ailliance Post-Market Clinical Study

a study on Spinal Deformity Spinal Degenerative Disorder Spinal Fusion Failure Spinal Trauma Spinal Tumor Case

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
completion around
Principal Investigator
by Aaron Clark, MD

Description

Summary

The purpose of this clinical study is to collect performance and safety data for post-market Medtronic devices indicated for cranial and/or spinal indication(s).

Subjects are enrolled and followed postoperatively to 24 months. The Ailliance clinical study is intended to collect data congruous with routine clinical care practices.

Official Title

The Ailliance Post-Market Clinical Study: All enablIng technoLogies, bioLogics, IDS, And Core spiNe produCt collEction

Keywords

Spinal Deformity, Spinal Degenerative Disorder, Spinal Fusion Failure, Spinal Trauma, Spinal Tumor Case, Spinal Cord Neoplasms, Spinal Neoplasms, Follow-up schedule: pre-operative baseline up to 24-months post-procedure

Eligibility

You can join if…

Open to people ages 18 years and up

  1. Subject provides written informed consent per institution and/or geographical requirements.
  2. Subject is intended to receive or be treated with an eligible Medtronic Cranial and Spinal Technology (CST) device(s) (see product appendices), used alone or in combination, for a cranial and/or spinal indication(s).
  3. Subject is at least 18 years of age or minimum legal age as required by local regulations.
  4. Subject agrees to complete all required assessments per the Schedule of Events.

You CAN'T join if...

  1. Subject is currently enrolled or plans to enroll in concurrent drug/device/biologic trial(s) that may confound this trial's results per investigator assessment (i.e. no required intervention that could affect interpretation of all-around device safety and or performance).
  2. Subject who is, or is expected to be, inaccessible for all required follow-up visits.
  3. Subject with exclusion criteria required by local law.
  4. Subject is considered vulnerable at the time of obtaining consent.

Locations

  • UCSF (UCSF) accepting new patients
    San Francisco California 94143 United States
  • University of California Davis Medical Center accepting new patients
    Sacramento California 95816 United States

Lead Scientist at UCSF

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Medtronic Spinal and Biologics
ID
NCT05856370
Study Type
Interventional
Participants
Expecting 1000 study participants
Last Updated